Você procurou por: alopekia (Finlandês - Inglês)

alopekia
alopecia*

alopekia (g3/ 4:
alopecia (g3/ 4:

ihottuma valoherkkyysreaktiot alopekia
photosensitivity reaction alopecia

alopekia akne ruusufinni ekseema
alopecia acne rosacea eczema

alopekia; ihotoksisuus (g3/ 4:
alopecia; skin toxicity (g3/ 4:

alopekia; kynsimuutokset (ei- vaikea)
skin and subcutaneous tissue disorders musculoskeletal and connective bone disorders metabolism and nutrition disorders

alopekia; eryteema; ihottuma; kynsimuutokset
skin and subcutaneous tissue disorders musculoskeletal and connective tissue disorders metabolism and nutrition disorders

epätavallinen hiustenlähtö tai oheneminen (alopekia)
unusual hair loss or thinning (alopecia)

3%); alopekia; iho-oireet (g3/4:
4%); (severe:

1, 2%) alopekia; kynsimuutokset (ei-vaikea)
1.2%) alopecia; nail disorders (no severe)

1, 7%) alopekia; iho-oireet (g3/4:
1.7%) alopecia; skin reaction (g3/4:0.8%)

iho ja ihonalainen alopekia kudos (g3/ 4: 10, 9%)
0.6%)

alopekia (g3/4:10, 9%)anoreksia (g3/4:
anorexia (g3/4:

alopekia (g3/4: 6 %); kynsimuutokset (g3/4: 2 %)
alopecia (g3/4: 6%); nail disorders (g3/4: 2%)

0, 4%) iho ja ihonalainen alopekia; kudos ihotoksisuus (g3/ 4:
4.3%); diarrhoea (g3/ 4:

alopekia; kynsimuutokset (vaikea 0, 7%); iho - oireet (g3/ 4:
myalgia (severe:

12, 0%); 0, 4%) ummetus (g3/4:0, 4%) alopekia (g3/4:
2.0%)dizziness (g3/4:

hyvin yleiset haittavaikutukset ≥ 10% potilaista alopekia; iho- oireet (g3/ 4:
alopecia; skin reaction (g3/ 4:

3%);hyvin yleiset haittavaikutukset 10% potilaista alopekia; iho-oireet (g3/4:
1.4%) arthralgiaanorexia infections (g3/4:

18 iho ja ihonalainen kudos:niistä 687 potilaasta, joilla todettiin alopekiaa kemoterapiahoidon lopussa, oireet jatkuivat edelleen 22 potilaalla keskimäärin 55 kuukauden seuranta-ajan jälkeen.
skin and subcutaneous tissue disorders alopecia was observed to be ongoing at the median follow-up time of 55 months in 22 patients out of the 687 patients with alopecia at the end of the chemotherapy.